High CCL5 Expression Is Associated With Osteosarcoma Metastasis and Poor Prognosis of Patients With Osteosarcoma

Molecular Medicine Reports - Greece
doi 10.3892/mmr.2017.7458
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Increased Six1 Expression Is Associated With Poor Prognosis in Patients With Osteosarcoma

Oncology Letters
Cancer ResearchOncology
2017English

Overexpression of P62 Is Associated With Poor Prognosis and Aggressive Phenotypes in Osteosarcoma

Oncology Letters
Cancer ResearchOncology
2018English

LDOC1 Regulates Wnt5a Expression and Osteosarcoma Cell Metastasis and Is Correlated With the Survival of Osteosarcoma Patients

Tumor Biology
MedicineCancer Research
2017English

Increased Expression of Membrane-Type Matrix Metalloproteinase-1 Is Correlated With Poor Prognosis in Patients With Osteosarcoma

International Journal of Oncology
Cancer ResearchOncology
2006English

Aberrant Expression of microRNA-99a and Its Target Gene mTOR Associated With Malignant Progression and Poor Prognosis in Patients With Osteosarcoma

OncoTargets and Therapy
OncologyPharmacology
2016English

High Expression of eIF3d Is Associated With Poor Prognosis in Patients With Gastric Cancer

Cancer Management and Research
Oncology
2017English

Elevated Expression of AKT2 Correlates With Disease Severity and Poor Prognosis in Human Osteosarcoma

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

Overexpression of EZH2 Is Associated With the Poor Prognosis in Osteosarcoma and Function Analysis Indicates a Therapeutic Potential

Oncotarget
Oncology
2016English

High Expression Level of MMP9 Is Associated With Poor Prognosis in Patients With Clear Cell Renal Carcinoma

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy